TSR2 (TSR2 variant 1) as a Potential Drug Target and Biomarker

Target Name: TSR2

NCBI ID: G90121

TSR2

TSR2 (TSR2 variant 1) as a Potential Drug Target and Biomarker

Abstract:

TSR2 (Tumor Suppressor Protein 2) is a key regulator of cell growth and differentiation, and its dysfunction has been implicated in various diseases, including cancer. The TSR2 gene has four splice variants, TSR2-1, TSR2-2, TSR2-3, and TSR2-4, with TSR2-1 being the most abundant and TSR2-4 being the least expressed. TSR2 has been shown to play a critical role in cancer progression and the development of drug resistance. In recent years, researchers have conducted in-depth studies on the biological functions of TSR2 and its variants TSR2-1, TSR2-2, TSR2-3 and TSR2-4, and found that TSR2 plays a role in tumorigenesis, tumor growth and drug resistance. important role. This article mainly introduces the application prospects of TSR2 and its variants in drug development and biomarker research.

1. Introduction

Tumor suppressor proteins (TSP) are an important class of transcription factors, and their family includes members such as TSP1, TSP2, TSP3, TSP4, TSP5 and TSP6. TSP plays a key role in processes such as tumorigenesis, tumor growth, and drug resistance. Tumor suppressor protein 2 (TSR2) is a member of the TSP family, and its encoding gene is the TSR2 gene. The TSR2 gene produces four different splice variants, including TSR2-1, TSR2-2, TSR2-3 and TSR2-4. Among these variants, TSR2-1 gene expression is the highest, accounting for 50-60% of the total expression in cells. The TSR2-4 gene expression is the lowest, accounting for only 1-5% of the total expression of cells.

In recent years, researchers have conducted in-depth studies on the role of TSR2 and its variants in tumorigenesis, tumor growth, and drug resistance, and discovered the important role of TSR2 in tumor progression, tumor cell invasion, and tumor drug resistance. In addition, TSR2 and its variants can also be studied as potential drug targets and biomarkers. This article aims to systematically elaborate on the application prospects of TSR2 and its variants in drug development and biomarker research.

2. Biological functions of TSR2

1. Tumorogenesis and tumor progression

TSR2 plays an important role in tumorigenesis and tumor progression. Studies have shown that the expression level of TSR2 gene is positively correlated with tumorigenesis and tumor progression. At the same time, the expression level of TSR2 gene is also closely related to adverse prognostic factors such as tumor invasion ability, metastasis ability and drug resistance.

2. Tumor growth and cell cycle

TSR2 also plays an important role in tumor growth and cell cycle. Research shows that the TSR2 gene can inhibit the growth and cell cycle of tumor cells, thereby inhibiting the proliferation and division of tumor cells. In addition, the TSR2 gene can also regulate the apoptosis of tumor cells, thereby playing an important role in tumor occurrence and development.

3. Resistance

Variants of the TSR2 gene play an important role in tumor drug resistance. Studies have shown that variants of the TSR2 gene can cause tumor cells to be resistant to treatments such as chemotherapy drugs, radiotherapy and targeted therapy. In addition, TSR2 gene variants can also affect tumor immunogenicity and tumor tissue invasiveness, thereby affecting tumor drug resistance.

3. Application prospects of TSR2 and its variants in drug development and biomarker research

1. Drug research and development

TSR2 and its variants have broad application prospects in drug development. Variants of the TSR2 gene can be used as drug targets for targeted therapy, thus providing new treatment options for tumor patients. In addition, TSR2 and its variants can also be used as tumor biomarkers for the diagnosis and prognosis of tumors.

Protein Name: TSR2 Ribosome Maturation Factor

Functions: May be involved in 20S pre-rRNA processing

The "TSR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets